Mosaic ImmunoEngineering Announces Upcoming Presentation at the 23rd Annual SoCalBio Conference

Presentation to highlight Mosaic's naturally-derived immuno-oncology candidate, MIE-101Intratumoral administration of MIE-101 activates immune cells to initiate potent, systemic and durable antitumor immunityNOVATO, CA / ACCESSWIRE / October 20, …